Smaglo BG - Search Results

1

Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.

AlDeghaither D, Smaglo BG, Weiner LM. AlDeghaither D, et al. Among authors: smaglo bg. J Clin Pharmacol. 2015 Mar;55 Suppl 3(0 3):S4-20. doi: 10.1002/jcph.407. J Clin Pharmacol. 2015. PMID: 25707963 Free PMC article. Review.

2

The development of immunoconjugates for targeted cancer therapy.

Smaglo BG, Aldeghaither D, Weiner LM. Smaglo BG, et al. Nat Rev Clin Oncol. 2014 Nov;11(11):637-48. doi: 10.1038/nrclinonc.2014.159. Epub 2014 Sep 30. Nat Rev Clin Oncol. 2014. PMID: 25265912 Free PMC article. Review.

3

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.

Deeken JF, Wang H, Hartley M, Cheema AK, Smaglo B, Hwang JJ, He AR, Weiner LM, Marshall JL, Giaccone G, Liu S, Luecht J, Spiegel JY, Pishvaian MJ. Deeken JF, et al. Cancer Chemother Pharmacol. 2018 Mar;81(3):587-596. doi: 10.1007/s00280-018-3533-8. Epub 2018 Feb 1. Cancer Chemother Pharmacol. 2018. PMID: 29392450 Clinical Trial.

4

A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.

Pishvaian MJ, Wang H, He AR, Hwang JJ, Smaglo BG, Kim SS, Weinberg BA, Weiner LM, Marshall JL, Brody JR. Pishvaian MJ, et al. Among authors: smaglo bg. Clin Cancer Res. 2020 Oct 1;26(19):5092-5101. doi: 10.1158/1078-0432.CCR-20-1301. Epub 2020 Jul 15. Clin Cancer Res. 2020. PMID: 32669374 Free PMC article. Clinical Trial.

5

Postresection chemotherapy for pancreatic cancer.

Smaglo BG, Pishvaian MJ. Smaglo BG, et al. Cancer J. 2012 Nov-Dec;18(6):614-23. doi: 10.1097/PPO.0b013e31827459d8. Cancer J. 2012. PMID: 23187850 Review.

6

Profile and potential of ixabepilone in the treatment of pancreatic cancer.

Smaglo BG, Pishvaian MJ. Smaglo BG, et al. Drug Des Devel Ther. 2014 Jul 14;8:923-30. doi: 10.2147/DDDT.S52964. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25075175 Free PMC article. Review.

7

Discordance of KRAS mutational status in a single colonic resection specimen in a patient with colorectal cancer: a case report and review of the literature.

Smaglo BG, Marshall JL. Smaglo BG, et al. Clin Colorectal Cancer. 2013 Sep;12(3):214-7. doi: 10.1016/j.clcc.2013.04.003. Epub 2013 Jun 4. Clin Colorectal Cancer. 2013. PMID: 23755925 Review. No abstract available.

8

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma.

Gabrielson A, Tesfaye AA, Marshall JL, Pishvaian MJ, Smaglo B, Jha R, Dorsch-Vogel K, Wang H, He AR. Gabrielson A, et al. Cancer Chemother Pharmacol. 2015 Nov;76(5):1073-9. doi: 10.1007/s00280-015-2852-2. Epub 2015 Oct 8. Cancer Chemother Pharmacol. 2015. PMID: 26449224 Free PMC article. Clinical Trial.

9

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM. Smaglo BG, et al. Oncotarget. 2015 Dec 22;6(41):43594-604. doi: 10.18632/oncotarget.6202. Oncotarget. 2015. PMID: 26498363 Free PMC article.

10

Approach to the medical management of surgically resectable gastric cancer.

Tesfaye A, Marshall JL, Smaglo BG. Tesfaye A, et al. Among authors: smaglo bg. Clin Adv Hematol Oncol. 2016 Feb;14(2):129-35. Clin Adv Hematol Oncol. 2016. PMID: 27057811 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page